Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634903 · ClinicalTrials.gov registry record · NA
Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 2,452
- Enrollment target
NCT04634903: Completed NA study, sponsored by Stony Brook University.
NCT04634903 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 2,452 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04634903, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,452 participants
- Enrollment target
Study Summary
Most mental health problems emerge by age 14, often leading to chronic impairments and adverse impacts for individuals, families, and societies. Any action-focused path to reducing the need-to-access gap will require moving beyond the dominant settings, formats, and systems that have constrained intervention delivery to date. In a fully-online trial, youths ages 13-16 will be randomized to 1 of 3 self-administered single-session interventions (SSIs): a behavioral activation SSI, targeting behavioral MD symptoms; an SSI teaching growth mindset, targeting cognitive MD symptoms; or a control SSI. The investigators will test each SSI's relative benefits, versus the control, on depressive symptoms and proximal outcomes such as hopelessness. Results will reveal whether SSIs that were designed to address behavioral versus cognitive symptoms differentially benefit adolescents with elevated depressive symptoms.
Primary Outcome
The Children's Depression Inventory (CDI) 2 - short form (CDI-SF) is a reliable, valid measure of youth depression severity, normed for youth age and sex and yielding raw scores ranging from 0-24, where higher scores indicate more severe symptoms of depression.
Interventions
- BEHAVIORAL Supportive Therapy SSI
- BEHAVIORAL Behavioral Activation SSI
- BEHAVIORAL Growth Mindset SSI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,452 participants |
| Start Date | 2020-11-19 |
| Est. Completion | 2021-03-15 |
| Phase | NA |
What the finished NCT04634903 record still lists
NCT04634903 is an interventional study that assigns participants to a tested intervention. Its 2,452 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% higher).
The record links to 0 conditions, and to 3 interventions - of which Supportive Therapy SSI is the first listed.
NCT04634903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04634903 about?
NCT04634903 is a clinical study titled "Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19". Most mental health problems emerge by age 14, often leading to chronic impairments and adverse impacts for individuals, families, and societies. Any action-focused path to reducing the need-to-access gap will require moving beyond the dominant settings, formats, and systems that have constrained int...
What is the current status of trial NCT04634903?
This trial is currently completed. It is a NA study. The enrollment target is 2,452 participants. The study started on 2020-11-19. Estimated completion is 2021-03-15.
What interventions are being tested in trial NCT04634903?
The interventions under investigation include: Supportive Therapy SSI (BEHAVIORAL), Behavioral Activation SSI (BEHAVIORAL), Growth Mindset SSI (BEHAVIORAL).
Who is sponsoring clinical trial NCT04634903?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04634903's enrollment target sits among peer trials
2,452 45th of 2000 higher than 1,956 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
- NCT06128304 · 2,436 participants · NA
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
- NCT06676904 · 2,433 participants · NA
Neonatal Platelet Transfusion Threshold Trial
- NCT05345951 · 2,425 participants · NA
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cannabis Use
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI